Ignite Creation Date:
2025-12-25 @ 3:26 AM
Ignite Modification Date:
2026-05-27 @ 7:02 AM
Study NCT ID:
NCT05288205
Status:
RECRUITING
Last Update Posted:
2025-04-04
First Post:
2022-03-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation
Sponsor:
Allist Pharmaceuticals, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
JAB-21822-1006
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None